Analytical Data
-
Gene name
PKCE
-
简介
PKCE proteins are calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine protein kinases. PKCE Protein, Human (His) is the recombinant human-derived PKCE protein, expressed by E. coli , with C-6*His labeled tag.
- Application
-
Alternative Names
Protein Kinase C Epsilon Type; nPKC-Epsilon; PRKCE; PKCE
-
Species
Human
-
Source
E. coli
-
Tag
C-6*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q02156
-
Expression Region
Q580-P737
-
Protein Length
Partial
-
Molecular Weight
20 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PKCE, or protein kinase C epsilon, is a member of the protein kinase C (PKC) family, which plays a critical role in various cellular processes, including growth, differentiation, and apoptosis. Research on PKCE has garnered significant attention due to its involvement in several pathophysiological conditions, notably cancer, cardiovascular diseases, and neurodegenerative disorders. The dysregulation of PKCE activity has been linked to tumor growth and metastasis, making it a potential biomarker and therapeutic target in oncology. Furthermore, its modulatory effects on signaling pathways have sparked interest in its role in heart disease and its neuroprotective properties. This has led to the exploration of PKCE as a target for drug development, aiming to harness its potential in therapeutic interventions. Advances in molecular biology and structural biology have facilitated the understanding of PKCE's structure and function, paving the way for the development of selective inhibitors or activators. Researchers are also investigating PKCE's role in specific cellular signaling networks, aiming to delineate its mechanisms of action further. Overall, the study of PKCE and its reassembled proteins represents a promising frontier in biomedical research, with the potential to contribute significantly to the development of novel therapies for various diseases.
